Sustainable replacement of EDTA-Biojarosite for commercial iron in the Fenton's and UV-Fenton's degradation of Rhowedamine B - a process optimization using Box-Behnken method
Biojarosite as a replacement for commercial iron catalyst in the oxidative degradation of the dye Rhodamine B was confirmed and established. Investigations on the oxidative degradation by Fenton's oxidation and UV-Fenton's oxidation with EDTA at neutral pH were conducted and degradation of...
Publié dans: | Water science and technology : a journal of the International Association on Water Pollution Research. - 1986. - 86(2022), 8 vom: 08. Okt., Seite 2008-2019 |
---|---|
Auteur principal: | |
Autres auteurs: | , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2022
|
Accès à la collection: | Water science and technology : a journal of the International Association on Water Pollution Research |
Sujets: | Journal Article Iron E1UOL152H7 Hydrogen Peroxide BBX060AN9V Edetic Acid 9G34HU7RV0 |
Résumé: | Biojarosite as a replacement for commercial iron catalyst in the oxidative degradation of the dye Rhodamine B was confirmed and established. Investigations on the oxidative degradation by Fenton's oxidation and UV-Fenton's oxidation with EDTA at neutral pH were conducted and degradation of target compound was evaluated. UV-Fenton's oxidation was shown to be efficient over Fenton's oxidation in the degradation of Rhodamine B with removal efficiency of 90.0%. Design of Experiments was performed with Box-Behnken design. Investigation was conducted for the predicted values separately for both Fenton's oxidation and UV-Fenton's oxidation and the Rhodamine B removal was taken as response. Variable parameters biojarosite, H2O2 dosage and EDTA were optimized in the range of 0.1-1 g/L, 2.94-29.4 mM and 10-100 mM, respectively. A quadratic regression model is fitted for both Fenton's and UV-Fenton's oxidation. Analysis of variance (ANOVA) is performed and model fit is discussed |
---|---|
Description: | Date Completed 02.11.2022 Date Revised 02.11.2022 published: Print Citation Status MEDLINE |
ISSN: | 0273-1223 |
DOI: | 10.2166/wst.2022.299 |